 |
Research Programs |
 |
|
|
Overview
The Office of Research Programs’ mission is to enhance and facilitate Departmental research activities through a coordinated, centralized system leading to increased productivity and revenue from research. It provides a comprehensive array of support services; helps assure compliance with federal regulations and institutional policies and procedures; and coordinates efforts with OUHSC’s Office of Research Administration, Institutional Review Board and General Clinical Research Center.
More more information in regards to our research programs please contact Sana Rettig by email at sana-rettig@ouhsc.edu
Click here for Pediatrics Research Seminars
|
|
Federally Funded Awards |
|
|
|
| Principal Investigator |
Project Name |
Sponsor |
| |
|
|
| Developmental & Behavioral Pediatrics |
|
|
| Bigfoot/Bonner |
Indian Country Child Trauma Center |
DMHS |
| Bonner/Balachova |
Development of Education Materials for Prevention of FAS in Russia |
CDC-AUCD |
| Bonner/Balachova |
Preventing FAS/ARND in Russian Children |
NIH/Fogarty Int'l Ctr. |
| Chaffin, M |
Alternatives for Families III-Violence Prevention Center |
CDC |
| Chaffin/Hecht |
Effectiveness trial Project Safecare for Child Neglect |
NIMH |
| Gurwitch, R |
Prevention of Secondary Disabilities in Native American Children w/Fetal Alcohol Spectrum Disorders |
IHS-Native American Research Ct on Health |
| Gurwitch, R |
Building FASD Systems: A Dissemination model |
CDC |
| McBride |
Professional Development In Autism Center |
U.S. Dept of Education |
| Schmidt/Chaffin |
State implementation of evidence-based practice II, Bridging science and practice |
NIH/OKDMHSA |
| Silovsky, J |
Prevention of Child Maltreatment in High Risk Families |
CDC |
| Swisher, L. |
Multi Systemic Therapy as Alternative to Placement |
OJA |
| Wolraich, M |
ADHD School Based Prevalence and Health Risk Behaviors |
CDC |
| Wolraich, M |
Sooner Success (CORE) |
DHHS/Health Resources & Srvs Adm/Maternal & Child Helath Bureau |
| |
|
|
| Diabetes/Endocrinology |
|
|
| Copeland, K |
Treatment Options for Type 2 Diab. in Children-Y5 |
NIH |
| Copeland, K |
Treatment Options for Type 2 Diab. in Children-Y6 |
NIH |
| Copeland, K |
Type 1 Diabetes TrialNet |
PHS/NIH |
| Gardner, A |
Exercise for Elderly Peripheral Revascularized Patients |
NIH |
| Gardner, A |
Home-based Vs. Supervised Exercise for Claudicants |
|
| |
|
|
| Genetics |
|
|
| Li, S. |
Chromosome Imaging Technique for Cancer Diagnosis |
NCI |
| Mulvihill, J. |
Neurofibromatosis 1 in Old Age: International Interdisciplinary Analyses of the Issues |
DOD via Army |
| Mulvihill, J. |
African-American Community Review of Genetic Research |
DHHS via NIH |
| Mulvihill, J. |
Using Third-Party Data in Pedigree and Subgroup Analyese |
DHHS via NIH |
| Mulvihill, J. |
Heartland Genetics and Newborn Screening Collaborative |
DHHS via PHS |
| Mulvihill, J. |
Heartland Genetics and Newborn Screening Collaborative |
DHHS via PHS |
| Mulvihill, J. |
CTSA Oklahoma Planning Grant |
DHHS via NIH |
| Mulvihill, J. |
NARCH 3 Student Development Program and Clinical Trial to Improve Outcomes in Fetal Alcohol syndrome |
DHHS via PHS |
| |
|
|
| Hematology/Oncology |
|
|
| Cain, J |
UTSW-Sickle Cell |
NIH/NHL |
| Cain, J |
Arginine Supplementation in Sickle Cell Anemia |
NHLBI |
| Cain, J |
SW Comp Sickle Cell Center Clinical Trials -CDATA |
NHLBI |
| Cain, J |
SW Comp Sickle Cell Center Clinical Trials-Priapism Study |
NHLBI |
| Cain, J |
Healthy/Ready to Work Transition Program |
HRSA/OSDH |
| McNall, R |
Children's Oncology Group Chair |
NIH/NCI/NCCF |
| Meyer, W |
Intergroup Rhabdomyosarcoma (Chair's Study Group) |
NIH/NCI/NCCF |
| Saxena, Kapil |
Rituximab for the treatment of inhibitors in hemophilia A |
NHLBI |
| Sexauer, C |
Hemophilia Comprehensive Clinic |
UTHSC-Houston |
| Sexauer, C |
Comprehensive Hemophilia Treatment Center… |
UTHSC-Houston |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Federally Funded Awards |
| Principal Investigator |
Project Name |
Sponsor |
| |
|
|
| Neonatology |
|
|
| Sekar, K |
Inhaled NO for the Prevention of CLD-Y5 |
NIH |
| |
|
|
| Nephrology |
|
|
| Turman, M |
Focal Segemental Glomerulosclerosis |
NIH |
| Turman, M |
Chronic Kidney Disease in Children |
NIH/DKUHD |
| |
|
|
| Rheumatology |
|
|
| O'Neil, K |
Dev. of Autoimmunity in Puberty in Childhood-SLE |
NIH |
|
|
Pharmaceutical and Foundation Awards |
|
|
|
| Principal Investigator |
Project Name |
Sponsor |
| |
|
|
| Critical Care |
|
|
| |
|
|
| Developmental & Behavioral Pediatrics |
|
|
| Lock, T |
An Open-Label Study for Long-Term Tolerability and Safety of Atomoxetine in Treating the Inattention, Impulsivity and Hyperactivity in Children w/Fetal Alcohol Syndrome or Effects. |
Eli Lilly & Co. |
| Lock, T |
Study of Safety & tolerability of Atomoxetine in treating Inattention, Impulsivity and Hyperactivity in Children w/Fetal Alcohol Syndrome or Effects |
Eli Lilly & Co. |
| Lock, T |
Open-Label Treatment with Atomoxetine Hydrochloride in Children and Adolescents w/ADHD and Comorbid Dyslexia. |
Eli Lilly & Co. |
| Lock, T |
Maintenance of Benefit after 8-Wk and 52-Wk Treatment w/Atomoxetine Hydrochloride in Adoles w/ADHD |
Eli Lilly & Co. |
| Mullins |
Infant Parenting Child Care Program |
Potts Foundation |
| |
|
|
| Diabetes/Endocrinology |
|
|
| Beck, J |
Hemoglobin A1c Cartridges for Pediatric Diabetes Patients |
OKCHF |
| Blackett, P |
Conducting Trials with Genotropin |
Pfizer, Inc. |
| Blackett, P |
National Cooperative Study(NCGS)Post Marketing |
Genentech Inc. |
| Blackett, P |
Goal-Setting According to Stage of Readiness for Obese Children |
OKCHF |
| Copeland, K |
Genetics and Neuroendocrinology of Short Stature |
Eli Lilly & Co. |
| Copeland, K |
American Norditropin: Web Enabled Research |
Novo Nordisk Pharm |
| Fields, D |
Developing Normative Body Composition Data in Early Infancy |
Life Measurements Inc |
| Sternlof, S |
Data and Statistical Analysis |
Schools for Healthy Lifestyles |
| |
|
|
| Genetics |
|
|
| Palmer, S. |
PKU Dietary Project |
OK Children's Health Fund |
| Williamson, L. |
Use of Complementary and Alternative Medicine in Patients with Hereditary Conditions |
PHF |
| |
|
|
| G.I. |
|
|
| Grunow, J |
Pantoprazole for Children 1 To 5 with GERD |
Wyeth, Inc |
| Grunow, J |
Pantoprazole for Infants 1-11 mo. with GERD |
Wyeth, Inc |
| |
|
|
| Hematology/Oncology |
|
|
| Cain, J |
A Randomized, open label…deferasirox in sickle cell |
Novartis Pharmaceutical |
| Saxena, K |
Phase IV study to determine PK response…Advate |
Baxter |
| Saxena, K |
Advate Antihemophilic Factor Plasma/Albumin Free… |
Baxter |
| Saxena, K |
Pediatric Hemophilia QOL Validation Study |
MEDTAP |
| Sexauer, C |
A study of immunologic safety for Alphanate… |
Grifos |
| Sexauer, C |
HTRS Registry -Epidemiology & Treatment… |
Novo Nordisk |
| |
|
|
| Infectious Disease |
|
|
| Chavez-Bueno |
Eval of MEDI-524 against RSV in outpatients |
MedImmune |
| Chavez-Bueno |
Eval of MEDI-524 against RSV in hospitalized pts. |
MedImmune |
| Stull, T |
Haemophilus Influenzae Iron/Heme Regulon |
PHF |
|
|
|
|
|
|
|
|
|
|
|
|
| Pharmaceutical and Foundation - Industry Sponsored |
| Principal Investigator |
Project Name |
Sponsor |
| |
|
|
| Neonatology |
|
|
| Escobedo |
Pantoprazole for the treatment of GERD in neonates and preterm infants |
Wyeth, Inc. |
| Sekar |
Inhaled NO for the Prevention of CLD-Y5 |
INO Therapeutics |
| Sekar |
NIPPV vs. SIMV in Infants |
Health Research Assoc. |
| Sekar |
Treatment of Neonatal Candidiasis |
Astellas |
| |
|
|
| Nephrology |
|
|
| Turman |
NCGS- Nat'l Coop. Growth Study for Nutropin … |
Genentech |
| Turman |
NCGS- substudy 11 |
Genentech |
| Turman |
NAPRTCS Registry |
NAPRTCS Consortium |
| Turman |
Polycystic Kidney Disease Registry |
Polycystic Kidney Res. Fnd. |
| Turman |
Venofer Iron Maint: Ped Chronic Kidney Dis. Pts. |
Luitpold, Inc. |
| |
|
|
| Pulmonology |
|
|
| Royall |
Cystic Fibrosis Center Grant (CF Foundation) |
CF Foundation |
| |
|
|
| Rheumatology |
|
|
| O'Neil |
Towards Biomarkers for Lupus Renal Disease |
Alliance of Lupus Research |
| O'Neil |
Triptorelin: Ovary Protection in Childhood Lupus |
FDA |
| O'Neil, K |
Pathogenesis of Childhood Lupus |
A C Rheumatology |
|
|
State Funded Awards |
|
|
|
| Principal Investigator |
Project Name |
Sponsor |
| |
|
|
| Community Pediatrics |
|
|
| Hester, C |
Obese Adolescents: Body, Vasc, Insulin Sensitivity |
COMAA |
| |
|
|
| Developmental & Behavioral Pediatrics |
|
|
| Silovsky, J |
Prevention of Child Maltreatment in High Risk Rural OK Families-HB1143 |
DHS |
| Swisher, L |
Evaluation of MST compared to residential placement |
OJA |
| |
|
|
| Diabetes/Endocrinology |
|
|
| Blackett, P |
Selected Polymorphisms, Fatty Acid Reg. In Obese Adolescents |
COMAA |
| Copeland, K |
Endocrine Long-Term Follow-up Contract |
OSDH |
| Copeland, K |
Research Causes and Cures for Diabetes |
OSDH |
| Fields, D |
Basis for Type 2 Diabetes in American Indian Youth |
OCAST |
| Fields, D |
Prenatal Maternal Weight Status and its Impact on Fetal Birth Weight & Composition |
COMAA |
| Gardner, A |
Home-based vs. Supervised Exercise for Claudicants |
OCAST |
| |
|
|
| Gen. Peds. |
|
|
| Gillaspy, S. |
Develop/Test of an Interactive Web Base Program |
COMAA |
| |
|
|
| Genetics |
|
|
| Li, S. |
Computer-Aided Chromosome imaging Technique for Cancer Diagnosis |
State |
| |
|
|
| Hematology/Oncology |
|
|
| Cain, J |
Sickle Cell |
DHS |
| |
|
|
| Infectious Disesases |
|
|
| Morton, D |
Haemophilus Influenzae OMP: Vaccine Candidates |
OCAST |
| |
|
|
| Rheumatology |
|
|
| O'Neil, K |
Complement Activating Antiphospholipid Antibody |
OCAST |
|
|
Contact Information |
|
|
|
Department of Pediatrics
University of Oklahoma Health Sciences Center
940 N.E. 13th Street, Oklahoma City, OK 73104
Phone: (405) 271-4401, Email: Department
Contact
|
|
|
